Bioventus Inc.BVSNASDAQ
Loading
Enterprise value to sales ratio
3Y CAGR
+7.5%/yr
vs -27.6%/yr prior
5Y CAGR
-12.3%/yr
Recent acceleration
Acceleration
+35.1pp
Accelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.33 | -22.2% |
| 2024 | 1.71 | +27.3% |
| 2023 | 1.34 | +25.5% |
| 2022 | 1.07 | -52.6% |
| 2021 | 2.26 | -12.2% |
| 2020 | 2.57 | -28.6% |
| 2019 | 3.60 | -7.6% |
| 2018 | 3.90 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |